Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Congenital cardiac liver cirrhosis with combined hepatocellular-cholangiocarcinoma-a case report.
El Dika I, Shia J, Chen CL, Paroder V, Carver A, Shamseddine A, Mukherji D, Sirohi B, Makondi PT, Asseily C, Matar CF, Elias R, Slater E, Rosenbaum MS, Paramesawaran R, Breitbart W, Abou-Alfa GK. El Dika I, et al. Among authors: paroder v. J Gastrointest Oncol. 2022 Dec;13(6):3321-3328. doi: 10.21037/jgo-21-878. J Gastrointest Oncol. 2022. PMID: 36636063 Free PMC article.
Maximizing response: a case report of salvage chemotherapy after immune checkpoint inhibition in a patient with previous chemo-refractory metastatic esophageal carcinoma.
Greally M, Agarwal R, El Dika I, Shamseddine A, El-Olayan A, Haibe Y, Paroder V, Shia J, Abou-Alfa GK, Ku GY. Greally M, et al. Among authors: paroder v. J Gastrointest Oncol. 2019 Apr;10(2):367-372. doi: 10.21037/jgo.2018.10.07. J Gastrointest Oncol. 2019. PMID: 31032108 Free PMC article.
Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Bates DDB, Mazaheri Y, Lobaugh S, Golia Pernicka JS, Paroder V, Shia J, Zheng J, Capanu M, Petkovska I, Gollub MJ. Bates DDB, et al. Among authors: paroder v. Abdom Radiol (NY). 2019 Nov;44(11):3701-3708. doi: 10.1007/s00261-019-02073-5. Abdom Radiol (NY). 2019. PMID: 31154482 Free PMC article.
Initial evaluation of dual-energy computed tomography as an imaging biomarker for hepatic metastases from neuroendocrine tumor of the gastrointestinal tract.
Cruz-Hernández E, Mahmood U, Golia Pernicka JS, Paroder V, Petkovska I, Gollub MJ, Shia J, Ganesh K, Bates DDB. Cruz-Hernández E, et al. Among authors: paroder v. Quant Imaging Med Surg. 2021 May;11(5):2085-2092. doi: 10.21037/qims-20-917. Quant Imaging Med Surg. 2021. PMID: 33936989 Free PMC article.
Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR, Chou JF, Keshinro A, Chapman WC Jr, Bauer PS, Mutch MG, Parikh PJ, Cercek A, Saltz LB, Gollub MJ, Romesser PB, Crane CH, Shia J, Markowitz AJ, Garcia-Aguilar J, Gönen M; Colorectal Cancer Disease Management Team of Memorial Sloan Kettering Cancer Center. Weiser MR, et al. JAMA Netw Open. 2021 Nov 1;4(11):e2133457. doi: 10.1001/jamanetworkopen.2021.33457. JAMA Netw Open. 2021. PMID: 34748003 Free PMC article.
Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: a case report.
de Castria TB, Tang L, Queiroz MM, Awni BM, Paroder V, Shamseddine A, Bariani GM, Mukherji D, Matar CF, Fernandes GDS, El-Olayan A, Sabatin F, Elias R, Gupta R, Janjigian YY, Abou-Alfa GK. de Castria TB, et al. Among authors: paroder v. J Gastrointest Oncol. 2021 Dec;12(6):3123-3132. doi: 10.21037/jgo-21-287. J Gastrointest Oncol. 2021. PMID: 35070435 Free PMC article.
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.
Cytryn SL, Moy RH, Cowzer D, Shah RH, Chou JF, Joshi SS, Ku GY, Maron SB, Desai A, Yang J, Sugarman R, Rao D, Goldberg Z, Charalambous C, Lapshina M, Antoine A, Socolow F, Trivedi N, Capanu M, Gerdes H, Schattner MA, Simmons M, Lacouture ME, Paroder V, Tang LH, Shia J, Ilson DH, Solit DB, Berger MF, Janjigian YY. Cytryn SL, et al. Among authors: paroder v. Lancet Oncol. 2023 Oct;24(10):1073-1082. doi: 10.1016/S1470-2045(23)00358-3. Epub 2023 Sep 1. Lancet Oncol. 2023. PMID: 37666264 Clinical Trial.
65 results